Elderly US patients not receiving chemo for AML

Tuesday 31 January 2012

A recent analysis suggests that over half of elderly patients with acute myeloid leukaemia (AML) are not receiving any chemotherapy. The research found that median survival as well as chemotherapy use declined with advancing age.


>> http://www.oncologystat.com/news/Many_Elderly_AML_Patients_Not_Receiving_Chemotherapy_US.html


Further information

Recent stories

Most people told to get a colonoscopy don't
>> Find out more

MASCC/ISOO early rate deadline approaching
>> Find out more

Ten biomarkers for lung cancer detection
>> Find out more

Book for high-level conference on health funding
>> Find out more

New strategy to help charities deal with fraud
>> Find out more

Seminar on financial sustainability for charities
>> Find out more

Diesel exhaust linked to lung cancer deaths
>> Find out more

Identify depressive symptoms early in breast cancer patients
>> Find out more

Antibiotics may help gastric DLBCL patients avoid chemo
>> Find out more

Early registration deadline for GI conference extended to Fri
>> Find out more

Medical paternalism: who knows best?
>> Find out more

Risk of fatal adverse events in VEGF-targeting cancer drugs
>> Find out more

EBMT 2012: registration open
>> Find out more

Latest issue of Human Medicines Highlights available
>> Find out more

No to abiraterone in England & Wales
>> Find out more

Vitamin E supplements linked to prostate cancer risk
>> Find out more

Aspirin: cancer prevention benefits outweigh risks for 55-75 age group
>> Find out more

How does prenatal chemotherapy exposure affect children?
>> Find out more

Colonoscopy with adenoma removal cut colorectal cancer deaths by 53%
>> Find out more

Warning about counterfeit Avastin
>> Find out more

European Oncology Nursing Society
Avenue E. Mounier 83
B-1200 Brussels
Belgium
Tel: +32 (0)2 779 9923
Fax: +32 (0)2 779 9937
eons.secretariat@cancernurse.eu